These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4013356)

  • 1. Splenectomy for myeloproliferative disorders.
    Wilson RE; Rosenthal DS; Moloney WC; Osteen RT
    World J Surg; 1985 Jun; 9(3):431-6. PubMed ID: 4013356
    [No Abstract]   [Full Text] [Related]  

  • 2. Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation.
    Santos FP; Tam CS; Kantarjian H; Cortes J; Thomas D; Pollock R; Verstovsek S
    Leuk Lymphoma; 2014 Jan; 55(1):121-7. PubMed ID: 23573823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenic artery embolization prior to splenectomy in end-stage polycythemia vera.
    Hocking WG; Machleder HI; Golde DW
    Am J Hematol; 1980; 8(1):123-7. PubMed ID: 7395859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypersplenism and splenectomy in lymphoproliferative and myeloproliferative disorders.
    Kesteven PJ; Pullan JM; Glass UH; Wetherley-Mein G
    Clin Lab Haematol; 1985; 7(4):297-306. PubMed ID: 3830529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycythaemia, myelofibrosis. Splenectomy, myeloid leukosis and polycythaemia.
    ASHER R
    Proc R Soc Med; 1955 Jul; 48(7):539-40. PubMed ID: 13245824
    [No Abstract]   [Full Text] [Related]  

  • 6. Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases.
    Brenner B; Nagler A; Tatarsky I; Hashmonai M
    Arch Intern Med; 1988 Nov; 148(11):2501-5. PubMed ID: 3190384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenectomy for agnogenic myeloid metaplasia.
    Coon WW; Liepman MK
    Surg Gynecol Obstet; 1982 Apr; 154(4):561-3. PubMed ID: 7064091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenectomy for splenomegaly and secondary hypersplenism.
    Coon WW
    World J Surg; 1985 Jun; 9(3):437-43. PubMed ID: 4013357
    [No Abstract]   [Full Text] [Related]  

  • 9. Symptomatic splenomegaly in polycythemia vera: a review of the indications for splenectomy and perioperative considerations.
    Logan MS; Watson CM; Nottingham JM
    Am Surg; 2009 May; 75(5):363-8. PubMed ID: 19445284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenectomy in myeloid metaplasia.
    Cabot EB; Brennan MF; Rosenthal DS; Wilson RE
    Ann Surg; 1978 Jan; 187(1):24-30. PubMed ID: 74243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased likelihood of post-polycythemia vera myelofibrosis in Ph-negative MPN patients with chromosome 12 abnormalities.
    Benton CB; Tanaka M; Wilson C; Pierce S; Zhou L; Cortes J; Kantarjian H; Verstovsek S
    Leuk Res; 2015 Apr; 39(4):419-23. PubMed ID: 25687833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloproliferative disorders.
    Schwartz SI
    Ann Surg; 1975 Oct; 182(4):464-71. PubMed ID: 1058648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
    Iványi JL; Marton E; Plander M
    Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgery in oncohematology: state of the art].
    Marmont AM; Spagliardi E; Abbo L; Longo A; Torelli P
    Minerva Chir; 1989 Feb; 44(4):643-6. PubMed ID: 2654737
    [No Abstract]   [Full Text] [Related]  

  • 15. [Myeloproliferative disorders].
    Hartwich G; Lutz H
    Med Klin; 1972 Feb; 67(6):183-9. PubMed ID: 4503295
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversal of bone marrow fibrosis and subsequent development of polycythemia in patients with myeloproliferative disorders.
    Talarico L; Wolf BC; Kumar A; Weintraub LR
    Am J Hematol; 1989 Apr; 30(4):248-53. PubMed ID: 2929585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycythemia vera with myelofibrosis and myeloid metaplasia. Acute hepatic failure following splenectomy.
    McBrine PA; Miller A; Zimelman AP; Koff RS
    Am J Clin Pathol; 1980 Nov; 74(5):693-6. PubMed ID: 7446477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pegylated interferon alpha - 2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial.
    Gowin K; Jain T; Kosiorek H; Tibes R; Camoriano J; Palmer J; Mesa R
    Leuk Res; 2017 Mar; 54():73-77. PubMed ID: 28113109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia.
    Petroianu A
    Int Surg; 1996; 81(2):177-9. PubMed ID: 8912088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenomegaly and hypersplenism.
    Bowdler AJ
    Clin Haematol; 1983 Jun; 12(2):467-88. PubMed ID: 6352112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.